3rd Quarter - Report
CURA STRATEGIES for PKD FOUNDATION
Firm
Client
Income
$10,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Federal funding for PKD research at the National Institutes of Health (NIH).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELYN HELMUS New | — |
| SCOTT C LEEZER | Aide to Senator Dick Durbin (D-IL) |
| PATRICK MEADE New | — |
Health Issues HCR
Policies to relating to organ donation (H.R. 4583/4582 & S. 1552, the Living Donor Protection Act; H.R. 3698, the Living Organ Donor Tax Credit Act) and research into polycystic kidney disease (H.R. 9169, the PKD Cures Act).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELYN HELMUS New | — |
| SCOTT C LEEZER | Aide to Senator Dick Durbin (D-IL) |
| PATRICK MEADE New | — |
Defense DEF
Inclusion of PKD as a covered topic area under the Department of Defense's Peer Reviewed Medical Research Program (PRMRP).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELYN HELMUS New | — |
| SCOTT C LEEZER | Aide to Senator Dick Durbin (D-IL) |
| PATRICK MEADE New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.